No prior CVD group (n = 1013) | Prior CVD group (n = 4996) | |||||
---|---|---|---|---|---|---|
Odds ratio | 95 % CI | P value | Odds ratio | 95 % CI | P value | |
Region (Europe as reference group) | 1.616 | 1.116; 2.355 | 0.011 | 0.248 | 0.212; 0.290 | <0.001 |
Age (per year) | 1.038 | 1.006; 1.072 | 0.020 | 1.012 | 1.001; 1.023 | 0.032 |
Sex (male as reference group) | 0.542 | 0.311; 1.009 | 0.053 | 0.535 | 0.444; 0.644 | <0.001 |
Diabetes duration (per year) | 1.011 | 0.989; 1.035 | 0.330 | 1.004 | 0.995; 1.013 | 0.358 |
Race (white as reference group) | ||||||
Asian | 0.632 | 0.136; 3.479 | 1.226 | 0.664; 2.275 | ||
Black | 0.710 | 0.371; 1.339 | 0.633 | 0.773 | 0.581; 1.023 | 0.226 |
Other | 1.53 | 0.313; 8.783 | 0.759 | 0.389; 1.451 | ||
BMI (18–25, reference group) (kg/m2) | ||||||
25–30 | 0.571 | 0.239; 1.298 | 1.029 | 0.735; 1.438 | ||
30–35 | 0.836 | 0.353; 1.884 | 0.224 | 1.083 | 0.778; 1.503 | 0.472 |
35–40 | 0.879 | 0.361;2.049 | 1.105 | 0.782; 1.560 | ||
>40 | 0.935 | 0.375; 2.246 | 1.287 | 0.891; 1.856 | ||
Statin use (no as reference) | 4.669 | 3.352; 6.550 | <0.001 | 4.276 | 3.526; 5.202 | <0.001 |
Aspirin use (no as reference) | 1.055 | 0.750; 1.482 | 0.759 | 1.369 | 1.174; 1.597 | <0.001 |
Creatinine, per umol/L | 1.007 | 0.982; 1.038 | 0.607 | 0.995 | 0.991; 1.000 | 0.034 |
ACR, per mg/mmol | 0.999 | 0.995; 1.003 | 0.485 | 0.999 | 0.997; 1.000 | 0.017 |
eGFR per mL/min/1.73 m2 | 1.006 | 0.993; 1.025 | 0.360 | 0.994 | 0.988; 1.000 | 0.036 |